Rapport Therapeutics, Inc. · NASDAQ:RAPP

Gault Cheryl sold 10,000 Rapport Therapeutics, Inc. shares (Form 4)

Traded Sep 30, 2026 · Filed Oct 1, 2026

On Sep 30, 2026, Gault Cheryl (Chief Operating Officer) sold 10,000 Rapport Therapeutics, Inc. shares at an average US$33.19 for US$332K under a trading plan, leaving 139,914 shares. Filed Oct 1, 2026 (Form 4).

Sold
10,000 shares
Price
US$33.19 average (US$33.04 to US$33.76)
Value
US$332K
Holding after
139,914 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 30, 2026Common StockSale7,925US$33.04141,989Direct
Sep 30, 2026Common StockSale2,075US$33.76139,914Direct

Source

View original at SEC

Related